Foreign firms spend £7.8bn buying up UK businesses
However, there was an overall reduction in the number of UK merger and acquisition (M&A) deals for the latest quarter.
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Foreign firms snapped up £7.8 billion worth of UK companies over the latest quarter as the recent rise in international owners continued, according to official figures.
The Office for National Statistics (ONS) said the value of inward mergers and acquisitions – where foreign companies buy UK firms – increased by £1.1 billion against the previous quarter.
It came despite an overall reduction in the number of UK merger and acquisition (M&A) deals over the three months to the end of September.
Deals completed over the period included Carlsberg’s move to take complete control of its brewing joint venture with Marston’s for £206 million.
Another notable deal was the £788 million takeover of FTSE 250 doors and windows specialist Tyman by US rival Quanex Building Products.
However, the value of deals involving UK firms or investors as buyers was down against the previous quarter.
The statistics body found that outward M&A deals – those where UK companies snap up businesses from overseas – was reported at £4 billion for the quarter, down £200 million against the previous period.
These deals included AstraZeneca’s deal to buy Amolyt Pharma – a company which makes treatments for endocrine diseases – for 1.05 billion US dollars (£830 million).
It also found deals involving UK firms buying other UK firms dropped to £2.1 billion from £3 billion.
In total, there were 436 merger and acquisition deals which took place over the quarter. This was around 10% lower than the second quarter of 2024.